12-6534150-T-C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000920777.1(GAPDH):​c.-182T>C variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.274 in 153,780 control chromosomes in the GnomAD database, including 6,356 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.27 ( 6309 hom., cov: 33)
Exomes 𝑓: 0.19 ( 47 hom. )

Consequence

GAPDH
ENST00000920777.1 5_prime_UTR

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.242

Publications

23 publications found
Variant links:
Genes affected
GAPDH (HGNC:4141): (glyceraldehyde-3-phosphate dehydrogenase) This gene encodes a member of the glyceraldehyde-3-phosphate dehydrogenase protein family. The encoded protein has been identified as a moonlighting protein based on its ability to perform mechanistically distinct functions. The product of this gene catalyzes an important energy-yielding step in carbohydrate metabolism, the reversible oxidative phosphorylation of glyceraldehyde-3-phosphate in the presence of inorganic phosphate and nicotinamide adenine dinucleotide (NAD). The encoded protein has additionally been identified to have uracil DNA glycosylase activity in the nucleus. Also, this protein contains a peptide that has antimicrobial activity against E. coli, P. aeruginosa, and C. albicans. Studies of a similar protein in mouse have assigned a variety of additional functions including nitrosylation of nuclear proteins, the regulation of mRNA stability, and acting as a transferrin receptor on the cell surface of macrophage. Many pseudogenes similar to this locus are present in the human genome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2014]
GAPDH-DT (HGNC:55492): (GAPDH divergent transcript)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.96).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.413 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000920777.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt

There are no transcript annotations for this variant.

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GAPDH
ENST00000920777.1
c.-182T>C
5_prime_UTR
Exon 1 of 9ENSP00000590836.1

Frequencies

GnomAD3 genomes
AF:
0.275
AC:
41717
AN:
151934
Hom.:
6293
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.380
Gnomad AMI
AF:
0.304
Gnomad AMR
AF:
0.278
Gnomad ASJ
AF:
0.169
Gnomad EAS
AF:
0.429
Gnomad SAS
AF:
0.222
Gnomad FIN
AF:
0.275
Gnomad MID
AF:
0.175
Gnomad NFE
AF:
0.208
Gnomad OTH
AF:
0.236
GnomAD4 exome
AF:
0.192
AC:
332
AN:
1728
Hom.:
47
Cov.:
0
AF XY:
0.201
AC XY:
230
AN XY:
1144
show subpopulations
African (AFR)
AF:
0.286
AC:
4
AN:
14
American (AMR)
AF:
0.196
AC:
18
AN:
92
Ashkenazi Jewish (ASJ)
AF:
0.250
AC:
2
AN:
8
East Asian (EAS)
AF:
0.375
AC:
6
AN:
16
South Asian (SAS)
AF:
0.190
AC:
72
AN:
378
European-Finnish (FIN)
AF:
0.143
AC:
6
AN:
42
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
8
European-Non Finnish (NFE)
AF:
0.188
AC:
204
AN:
1084
Other (OTH)
AF:
0.233
AC:
20
AN:
86
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
10
21
31
42
52
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.275
AC:
41776
AN:
152052
Hom.:
6309
Cov.:
33
AF XY:
0.278
AC XY:
20637
AN XY:
74350
show subpopulations
African (AFR)
AF:
0.381
AC:
15805
AN:
41488
American (AMR)
AF:
0.278
AC:
4241
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.169
AC:
585
AN:
3462
East Asian (EAS)
AF:
0.428
AC:
2210
AN:
5160
South Asian (SAS)
AF:
0.220
AC:
1065
AN:
4830
European-Finnish (FIN)
AF:
0.275
AC:
2906
AN:
10576
Middle Eastern (MID)
AF:
0.168
AC:
49
AN:
292
European-Non Finnish (NFE)
AF:
0.208
AC:
14132
AN:
67950
Other (OTH)
AF:
0.240
AC:
506
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1534
3069
4603
6138
7672
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
408
816
1224
1632
2040
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.226
Hom.:
11118
Bravo
AF:
0.280
Asia WGS
AF:
0.381
AC:
1323
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.96
CADD
Benign
8.6
DANN
Benign
0.70
PhyloP100
-0.24
PromoterAI
-0.012
Neutral
Mutation Taster
=300/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs6489721; hg19: chr12-6643316; API